Driving Drug Performance Through Consumer Behavior Study
Business Problem
A pharma giant sought to deep dive into oncologist behavior in the USA market to track awareness, perception and behavior with respect to its drug in the MBC treatment area.
What we did and how
Analyzed the current therapy usage in the metastatic setting
Measured the awareness of new agents in development
Assessed oncologist attitudes and perceptions on targeted therapies
Key insights
We assessed the prescription drivers for both inline and pipeline drugs. We carried out a detailed analysis on the treatment of MBC Patients and assessed unaided and aided awareness of agents in development. We looked at the MBC therapy attribute assessment and perceptual mapping for clinical endpoints.
Client Impact :
The company got a detailed view of the consumer attitude and perceptions, enabling it to sharpen the messaging for improved impact.